Yseop
- Company typePrivate
- Founded2011
- HeadquartersParis, France
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
Yseop firmographics
Firmographics- Name
- Yseop
- Legal name
- YSEOP
- Website
- https://yseop.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Yseop industry classification
Industry- Product category
- Life Sciences AI Software
- NAICS
- Custom Computer Programming Services (541511), Computer Systems Design Services (541512), Computer Systems Design and Related Services (54151)
- SIC
- Services-Computer Programming Services (7371), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industry
- Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB)
Keywords
Where Yseop is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices3 records
Markets served
Yseop business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- Yseop Copilot Platform Subscription: SaaS platform subscription for regulatory and medical writing automation. Enterprise licensing model with pricing based on document volume, users, and automation pack selections. Includes platform access, support, and continuous updates.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS Platform |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Yseop product offering
Product offeringCore offering
Yseop builds and sells Yseop Copilot, an AI-powered enterprise SaaS platform that automates the generation of regulatory and clinical documents (clinical study reports, patient narratives, safety reports, preclinical and CMC submissions) for pharmaceutical and life sciences customers. The platform is built on a neuro-symbolic AI architecture combining LLMs with symbolic reasoning and deterministic RAG to produce traceable, validated, audit-ready text. The company also sells the Augmented Analyst platform for financial and performance reporting, deployed by enterprises such as L'Oréal, with applications including the Augmented Medical Writer and Augmented Financial Analyst.
Product overview
Yseop is a B2B AI software company offering a unified platform portfolio centered on Yseop Copilot and the Augmented Analyst platform. Yseop Copilot is the primary enterprise platform for life sciences companies, providing AI-powered document automation with neuro-symbolic AI architecture for regulatory-grade reliability. The Augmented Analyst platform serves both life sciences and financial services, supporting Augmented Medical Writer and Augmented Financial Analyst applications. The platform operates through modular automation packs including Clinical Study Report (CSR), Patient Narrative, Summary Clinical Safety, Preclinical Study Report, and Quality Overall Summary (QOS) automation for regulatory submissions. Business Intelligence Report Automation extends capabilities to enterprise BI tools. All products emphasize traceability, compliance, and human control in regulated environments.
Differentiator
Problem solved
Functional benefit
Brands
- Yseop Copilot: AI-powered platform that acts as a digital colleague for scientific writers, enabling automation of regulatory and clinical document generation with full traceability and compliance.
- Augmented Analyst
- Augmented Medical Writer
Products and services
- Yseop Copilot Primary enterprise AI platform for life sciences that automates regulatory and clinical document generation workflows (CSRs, patient narratives, SCS, preclinical and CMC/QOS submissions) with full traceability, GxP-compliant audit trail, and human-in-the-loop approval. Built on a neuro-symbolic AI architecture combining LLMs with symbolic reasoning and deterministic RAG, with native integrations into Microsoft Word and Veeva Vault RIM.
- Augmented Analyst AI-powered NLP platform that analyzes enterprise data and delivers automated insight and document generation across financial, performance, credit risk, and BI reporting use cases. Comprises applications including the Augmented Medical Writer and Augmented Financial Analyst and integrates directly with BI tools such as Tableau, Qlik, and Power BI to turn structured data into written narratives.
Quantifiable outcome
- Less than 7% of content requires re-authoring (validated against regulatory rules)
- +5 more outcomes
Companies that use Yseop
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles2 records
Yseop technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability8 records
Feature6 records
Yseop partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Veeva SystemscoreYseop joined Veeva's AI Partner Program. Yseop Copilot integrates with Veeva Vault RIM for single-click document generation in medical writing. The partnership enables mutual life sciences customers to improve visibility, data quality, and agility in regulatory document workflows.
- Amazon Web Services (AWS)coreAWS provides Yseop's cloud infrastructure, security, and scalability. Yseop leverages AWS services including Amazon Sagemaker, Amazon Bedrock, Amazon EKS, Amazon RDS, AWS Inferentia, and EC2 for its LLM ecosystem and AI capabilities. AWS partnership enables enterprise-grade security, data localization compliance, and access to advanced AI capabilities within a fully managed private cloud environment.
- CognizantminorCognizant and Yseop announced a partnership to scale medical writing through generative AI. Cognizant's AI and industry expertise combined with Yseop's platform aims to improve productivity of scientific writers across the life sciences value chain.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Yseop competitors and assessment
Company assessmentDirect peers
- Automated Insights: Automated Insights (Wordsmith platform) pioneered NLG for automated report generation across business intelligence, finance, and other data-driven verticals. Directly comparable to Yseop's Augmented Analyst for automated narrative generation from structured data.
- Arria NLG: Arria NLG is a direct competitor offering Natural Language Generation technology that converts structured data into written narratives for enterprise reporting, financial services, and life sciences. It is the closest comparable in pure NLG technology to Yseop's core competency.
Emerging players
- Saama Technologies: Saama provides AI-driven clinical trial analytics and lifecycle management technology for pharma, including patient narrative and CSR-adjacent capabilities. Comparable as an emerging AI platform targeting pharma clinical operations with similar buyer personas.
- Deep 6 AI: Deep 6 AI uses AI to mine clinical trial data and accelerate patient recruitment and trial operations. Adjacent AI-for-clinical-trials vendor with overlap in pharma R&D AI tooling, though focused on trial feasibility rather than document generation.
- Mendel: Mendel applies AI/ML to structure clinical and medical record data for pharma R&D and clinical trial use cases. Comparable as an emerging AI-native vendor serving pharma with NLP-driven document/data intelligence, though focused on upstream data structuring rather than regulatory document generation.
Broad incumbents
- IQVIA: IQVIA is the largest CRO with deep technology capabilities including Linguamatics NLP and a clinical analytics platform. Operates adjacent to Yseop in pharma R&D IT and competes for similar budget allocations from pharma medical-writing and regulatory affairs teams.
- OpenAI: OpenAI provides the underlying LLM technology used by many generative AI platforms and is rapidly building enterprise compliance, retrieval, and audit features that compete with specialized NLG vendors like Yseop. Threatens Yseop's differentiation as generic LLMs become more reliable for regulated use cases.
- Narrative Science (Salesforce): Narrative Science pioneered NLG for BI dashboards (Tableau, Power BI) and was acquired by Salesforce to bring natural language narratives into the CRM/analytics stack. Comparable to Yseop's BI report automation extensions for Tableau, Qlik, and Power BI, but now embedded within the Salesforce ecosystem.
- Veeva Systems: Veeva is Yseop's primary channel partner (AI Partner Program) but also a potential competitor with its own Vault platform and AI roadmap for regulatory content management. Veeva owns the workflow; Yseop plugs into it — making Veeva both essential partner and existential risk.
- Microsoft (Copilot / Microsoft 365): Microsoft is Yseop's integration partner (Word) but also the broadest incumbent threat: Microsoft 365 Copilot and Azure OpenAI Service are rapidly improving on enterprise compliance and grounding features and could be deployed as alternative regulatory-writing tools inside pharma IT environments.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Yseop social profiles
Digital presenceYseop compliance and trust
Trust signalCompliance2 records
Yseop financial estimates
Financial estimateRevenue estimate
Valuation estimate
Yseop leadership team
Management profileNumber of profiles
Profiles8 records
Yseop funding detail
Funding detailFunding overview
Funding rounds4 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Yseop M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Yseop
What does Yseop do?
Yseop builds and sells Yseop Copilot, an AI-powered enterprise SaaS platform that automates the generation of regulatory and clinical documents (clinical study reports, patient narratives, safety reports, preclinical and CMC submissions) for pharmaceutical and life sciences customers. The platform is built on a neuro-symbolic AI architecture combining LLMs with symbolic reasoning and deterministic RAG to produce traceable, validated, audit-ready text. The company also sells the Augmented Analyst platform for financial and performance reporting, deployed by enterprises such as L'Oréal, with applications including the Augmented Medical Writer and Augmented Financial Analyst.
Is Yseop a public or private company?
Yseop is a private company. It is classified as venture growth investor backed and is currently operating.
When was Yseop founded?
Yseop was founded in 2011. It employs 101 to 250 people.
Where is Yseop based?
Yseop is headquartered in Paris, France, in the Europe region.
How does Yseop make money?
One revenue line is on record: yseop Copilot Platform Subscription.
Who are Yseop's main competitors?
Direct peers on record are Automated Insights and Arria NLG. Emerging players are Saama Technologies, Deep 6 AI and Mendel. Broad incumbents are IQVIA, OpenAI, Narrative Science (Salesforce), Veeva Systems and Microsoft (Copilot / Microsoft 365).
Does Yseop have an API?
No public API is recorded for Yseop.
What industry is Yseop in?
Yseop's product category is Life Sciences AI Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 541511 and its SIC code is 7371.